AMT Stock Recent News
AMT LATEST HEADLINES
In the most recent trading session, American Tower (AMT) closed at $236.16, indicating a +1.08% shift from the previous trading day.
American Tower Corporation (NYSE:AMT ) Citi's 2024 Global TMT Conference September 4, 2024 2:10 PM ET Company Participants Steve Vondran - President & CEO Conference Call Participants Michael Rollins - Citi Michael Rollins Welcome to Citi's 2024 Global TMT Conference. For those of you I haven't met yet, I'm Mike Rollins with Citi Research and we're pleased to welcome American Tower's President and CEO, Steve Vondran.
The month of September is, infamously, a period of weak seasonality for the stock market.
REITs are in a bear market. But I have still had some big wins this year. I discuss 4 of my best investments of 2024 so far.
In July 2024, we received $1,683.75 in dividend income. We have been buying at least 4 shares of SCHD every single week. I accepted a long time ago that Leggett & Platt's dividend cut was terrible.
It pays to select 'first round draft picks' for one's portfolio to help achieve your long-term financial goals. American Tower appears to be on such top pick for stable income and solid total returns from high quality assets. AMT's strong fundamentals, diverse portfolio, and strategic focus on high-demand sectors make it a solid investment opportunity.
LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient has been dosed in a Phase I/IIa clinical trial of AMT-191 for the treatment of Fabry disease, a rare, inherited genetic disease. The Phase I/IIa study is a multi-center, open-label trial being conducted in the United States with two dose-escalating cohorts assessing the safety, tolerability and early signs of efficacy of AMT-191 in individuals with Fabry disease.
NEW YORK--(BUSINESS WIRE)--Nuveen announced today that Glass Lewis, a leading independent proxy advisory firm, recommended that shareholders vote on the WHITE proxy card FOR ALL Board nominees of Nuveen New York AMT-Free Quality Municipal Income Fund (NYSE: NRK), and AGAINST the proposal to terminate Nuveen as the investment advisor put forth by a dissident shareholder in connection with the Fund's annual meeting scheduled for August 15, 2024. Glass Lewis' recommendation follows a report from I.
American Tower Corporation (NYSE:AMT ) TD Cowen 10th Annual Communications Infrastructure Summit Call August 13, 2024 1:15 PM ET Company Participants Steven Vondran - President and Chief Executive Officer Conference Call Participants Gregory Williams - TD Cowen Gregory Williams Let's get started. Good morning.
American Tower (AMT) is likely to gain from the rising demand for wireless connectivity and its strategic acquisitions despite customer concentration and consolidation woes.